{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:35:59Z","timestamp":1785281759709,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T00:00:00Z","timestamp":1352246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00423-012-1026-5","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T07:35:18Z","timestamp":1352187318000},"page":"113-120","source":"Crossref","is-referenced-by-count":28,"title":["BMD improvements after operation for primary hyperparathyroidism"],"prefix":"10.1007","volume":"398","author":[{"given":"Lars","family":"Rolighed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Heickendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Sikjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Mosekilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,7]]},"reference":[{"issue":"2","key":"1026_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP, Khan AA, Potts JT Jr, Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94(2):335\u2013339","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1026_CR2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-11-0589","volume":"165","author":"J Bollerslev","year":"2011","unstructured":"Bollerslev J, Marcocci C, Sosa M, Nordenstrom J, Bouillon R, Mosekilde L (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165(6):851\u2013864","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 2","key":"1026_CR3","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1002\/jbmr.5650061421","volume":"6","author":"AM Parfitt","year":"1991","unstructured":"Parfitt AM, Rao DS, Kleerekoper M (1991) Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res 6(Suppl 2):S97\u2013S101, discussion S121-S124","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1026_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","volume":"114","author":"NIH","year":"1991","unstructured":"NIH (1991) NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114(7):593\u2013597","journal-title":"Ann Intern Med"},{"issue":"12","key":"1026_CR5","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT Jr, Fuleihan G, Kleerekoper M, Neer R, Peacock M et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87(12):5353\u20135361","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1026_CR6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00423-009-0533-5","volume":"394","author":"Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H, European Society of Endocrine Surgeons","year":"2009","unstructured":"Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H, European Society of Endocrine Surgeons (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394(5):761\u2013764","journal-title":"Langenbecks Arch Surg"},{"issue":"9","key":"1026_CR7","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E et al (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93(9):3462\u20133470","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"1026_CR8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341(17):1249\u20131255","journal-title":"N Engl J Med"},{"issue":"3","key":"1026_CR9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","volume":"88","author":"MR Rubin","year":"2003","unstructured":"Rubin MR, Lee KH, McMahon DJ, Silverberg SJ (2003) Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88(3):1174\u20131178","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1026_CR10","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","volume":"90","author":"MR Rubin","year":"2005","unstructured":"Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ (2005) Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 90(6):3326\u20133330","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1026_CR11","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O et al (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(5):1687\u20131692","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1026_CR12","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G et al (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114\u20133121","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1026_CR13","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415\u20135422","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1026_CR14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","volume":"94","author":"R Eastell","year":"2009","unstructured":"Eastell R, Arnold A, Brandi ML, Brown EM, D\u2019Amour P, Hanley DA et al (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2):340\u2013350","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1026_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2):351\u2013365","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1026_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","volume":"69","author":"L Mosekilde","year":"2008","unstructured":"Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69(1):1\u201319","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1026_CR17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S8756-3282(97)00078-1","volume":"21","author":"P Christiansen","year":"1997","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Charles P et al (1997) Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 21(1):93\u201399","journal-title":"Bone"},{"issue":"5","key":"1026_CR18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S8756-3282(99)00208-2","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L et al (1999) Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study. Bone 25(5):597\u2013602","journal-title":"Bone"},{"issue":"5","key":"1026_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S8756-3282(99)00207-0","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L et al (1999) Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 25(5):589\u2013595","journal-title":"Bone"},{"issue":"5","key":"1026_CR20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","volume":"68","author":"B Moosgaard","year":"2008","unstructured":"Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L (2008) Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) 68(5):707\u2013715","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1\u20132","key":"1026_CR21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2009.10.010","volume":"411","author":"CS Hojskov","year":"2010","unstructured":"Hojskov CS, Heickendorff L, Moller HJ (2010) High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin Chim Acta 411(1\u20132):114\u2013116","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1026_CR22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/8756-3282(94)00054-9","volume":"16","author":"B Abrahamsen","year":"1995","unstructured":"Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H (1995) Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 16(3):385\u2013390","journal-title":"Bone"},{"issue":"13","key":"1026_CR23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/archinte.141.13.1761","volume":"141","author":"FW Lafferty","year":"1981","unstructured":"Lafferty FW (1981) Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch Intern Med 141(13):1761\u20131766","journal-title":"Arch Intern Med"},{"issue":"8","key":"1026_CR24","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92(8):3001\u20133005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1026_CR25","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/jbmr.5650061413","volume":"6","author":"FW Lafferty","year":"1991","unstructured":"Lafferty FW (1991) Differential diagnosis of hypercalcemia. J Bone Miner Res 6(Suppl 2):S51\u2013S59, discussion S61","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1026_CR26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","volume":"95","author":"S Sankaran","year":"2010","unstructured":"Sankaran S, Gamble G, Bolland M, Reid IR, Grey A (2010) Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 95(4):1653\u20131662","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1026_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","volume":"90","author":"M Peacock","year":"2005","unstructured":"Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D (2005) Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90(1):135\u2013141","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1026_CR28","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","volume":"89","author":"AA Khan","year":"2004","unstructured":"Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AY et al (2004) Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89(7):3319\u20133325","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"1026_CR29","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2165\/00003495-200666170-00004","volume":"66","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P (2006) Current pharmacological options for the management of primary hyperparathyroidism. Drugs 66(17):2189\u20132211","journal-title":"Drugs"},{"issue":"9041","key":"1026_CR30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group. Lancet 348(9041):1535\u20131541","journal-title":"Lancet"},{"issue":"4","key":"1026_CR31","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/er.2001-6002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 23(4):540\u2013551","journal-title":"Endocr Rev"},{"issue":"9","key":"1026_CR32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archsurg.141.9.885","volume":"141","author":"LH VanderWalde","year":"2006","unstructured":"VanderWalde LH, Liu IL, O\u2019Connell TX, Haigh PI (2006) The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Arch Surg 141(9):885\u2013889, discussion 889\u2013891","journal-title":"Arch Surg"},{"issue":"4","key":"1026_CR33","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","volume":"90","author":"A Grey","year":"2005","unstructured":"Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 90(4):2122\u20132126","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1026_CR34","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.85.10.3541","volume":"85","author":"V Kantorovich","year":"2000","unstructured":"Kantorovich V, Gacad MA, Seeger LL, Adams JS (2000) Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 85(10):3541\u20133543","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1026_CR35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","volume":"36","author":"ML Isidro","year":"2009","unstructured":"Isidro ML, Ruano B (2009) Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 36(2):305\u2013310","journal-title":"Endocrine"},{"issue":"6","key":"1026_CR36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.surg.2008.06.032","volume":"144","author":"EG Grubbs","year":"2008","unstructured":"Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB et al (2008) Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery 144(6):852\u2013858, discussion 858\u2013859","journal-title":"Surgery"},{"issue":"2","key":"1026_CR37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/157488611795684613","volume":"6","author":"L Rolighed","year":"2011","unstructured":"Rolighed L, Bollerslev J, Mosekilde L (2011) Vitamin D treatment in primary hyperparathyroidism. Curr Drug Saf 6(2):100\u2013107","journal-title":"Curr Drug Saf"},{"issue":"6","key":"1026_CR38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","volume":"107","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Shane E, Dempster DW, Bilezikian JP (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107(6):561\u2013567","journal-title":"Am J Med"},{"issue":"6","key":"1026_CR39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF03344140","volume":"29","author":"P Boudou","year":"2006","unstructured":"Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC (2006) A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 29(6):511\u2013515","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1026_CR40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","volume":"63","author":"B Moosgaard","year":"2005","unstructured":"Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63(5):506\u2013513","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1026_CR41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2265.2010.03906.x","volume":"74","author":"AK Amstrup","year":"2011","unstructured":"Amstrup AK, Rejnmark L, Vestergaard P, Sikjaer T, Rolighed L, Heickendorff L et al (2011) Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls\u2014a cross-sectional study. Clin Endocrinol (Oxf) 74(1):130\u2013136","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4 Pt 1","key":"1026_CR42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajh\/1.4.397","volume":"1","author":"L Lind","year":"1988","unstructured":"Lind L, Wengle B, Wide L, Sorensen OH, Ljunghall S (1988) Hypertension in primary hyperparathyroidism\u2014reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. Am J Hypertens 1(4 Pt 1):397\u2013402","journal-title":"Am J Hypertens"},{"issue":"2","key":"1026_CR43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/157488611795684703","volume":"6","author":"P Vestergaard","year":"2011","unstructured":"Vestergaard P, Thomsen SS (2011) Medical treatment of primary, secondary, and tertiary hyperparathyroidism. Curr Drug Saf 6(2):108\u2013113","journal-title":"Curr Drug Saf"},{"issue":"6","key":"1026_CR44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.surg.2004.06.059","volume":"136","author":"EG Almqvist","year":"2004","unstructured":"Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J (2004) Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery 136(6):1281\u20131288","journal-title":"Surgery"},{"issue":"5","key":"1026_CR45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S8756-3282(00)00260-X","volume":"26","author":"T Steiniche","year":"2000","unstructured":"Steiniche T, Christiansen P, Vesterby A, Ullerup R, Hessov I, Mosekilde LE et al (2000) Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment. Bone 26(5):535\u2013543","journal-title":"Bone"},{"issue":"5","key":"1026_CR46","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen S, Hauge EM, Rasmussen L, Jensen JE, Brixen K (2012) Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism. A 1-year prospective controlled study using high resolution peripheral quantitative computed tomography. J Bone Miner Res 27(5):1150\u20131158","journal-title":"J Bone Miner Res"},{"issue":"7261","key":"1026_CR47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","volume":"321","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321(7261):598\u2013602","journal-title":"BMJ"},{"issue":"10","key":"1026_CR48","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O\u2019Fallon W, Riggs B (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14(10):1700\u20131707","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1026_CR49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/bjs.7044","volume":"97","author":"A Sitges-Serra","year":"2010","unstructured":"Sitges-Serra A, Garcia L, Prieto R, Pena MJ, Nogues X, Sancho JJ (2010) Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women. Br J Surg 97(7):1013\u20131019","journal-title":"Br J Surg"},{"issue":"5","key":"1026_CR50","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1210\/jc.2011-3072","volume":"97","author":"MD Walker","year":"2012","unstructured":"Walker MD, Dempster DW, McMahon DJ, Udesky J, Shane E, Bilezikian JP et al (2012) Effect of renal function on skeletal health in primary hyperparathyroidism. J Clin Endocrinol Metab 97(5):1501\u20131507","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1026_CR51","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1998.13.7.1167","volume":"13","author":"K Stone","year":"1998","unstructured":"Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR (1998) Hormonal predictors of bone loss in elderly women: a prospective study. The study of osteoporotic fractures research group. J Bone Miner Res 13(7):1167\u20131174","journal-title":"J Bone Miner Res"},{"issue":"Suppl 102","key":"1026_CR52","first-page":"1","volume":"109","author":"P Christiansen","year":"2001","unstructured":"Christiansen P (2001) The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. APMIS 109(Suppl 102):1\u201352","journal-title":"APMIS"},{"issue":"5","key":"1026_CR53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00223-010-9416-6","volume":"87","author":"AK Amstrup","year":"2010","unstructured":"Amstrup AK, Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L (2010) Effects of smoking on severity of disease in primary hyperparathyroidism. Calcif Tissue Int 87(5):406\u2013413","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1026_CR54","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/SLA.0b013e31824dad7d","volume":"255","author":"MW Yeh","year":"2012","unstructured":"Yeh MW, Wiseman JE, Ituarte PH, Pasternak JD, Hwang RS, Wu B et al (2012) Surgery for primary hyperparathyroidism: are the consensus guidelines being followed? Ann Surg 255(6):1179\u20131183","journal-title":"Ann Surg"},{"issue":"6","key":"1026_CR55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/qjmed\/hcr225","volume":"105","author":"BL Langdahl","year":"2012","unstructured":"Langdahl BL, Ralston SH (2012) Diagnosis and management of primary hyperparathyroidism in Europe. QJM 105(6):519\u2013525","journal-title":"QJM"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-012-1026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-012-1026-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-012-1026-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:20:10Z","timestamp":1714533610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-012-1026-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1007\/s00423-012-1026-5","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,7]]}}}